Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
05/2003
05/07/2003EP1307462A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307453A2 Dihydronaphthyridine- and dihydropyrrolopyridine-derivated compounds as potassium channel openers
05/07/2003EP1307450A2 2-(4-pyrdyl)amino-6-dialkoxyphenyl-pyrido(2.3-d)pyrimidin-7-ones
05/07/2003EP1307449A1 1,4-dihydropyridines as bradykinin antagonists
05/07/2003EP1307448A1 Tartrate salts of thiazolidinedione derivative
05/07/2003EP1307447A2 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
05/07/2003EP1307443A2 Novel substituted diaryl azepine derivatives as integrin ligands
05/07/2003EP1307438A1 Novel coumarin derivatives and the salts thereof, a process for the preparation thereof and their use in the pharmaceutical field
05/07/2003EP1307432A1 Cyclic oxyguanidine protease inhibitors
05/07/2003EP1307430A1 Nonpeptide substituted spirobenzoazepines as vasopressin antagonists
05/07/2003EP1307425A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides
05/07/2003EP1307245A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter
05/07/2003EP1307229A1 Combination preparation with an er-beta selective estrogen and a serm or antiestrogen
05/07/2003EP1307226A2 Vitronectin receptor antagonist pharmaceuticals
05/07/2003EP1307219A2 Methods of inhibiting binding of beta-sheet fibril to rage and consequences thereof
05/07/2003EP1307216A1 Polymer-modified bioactive synthetic chemokines, and methods for their manufacture and use
05/07/2003EP1307209A1 Cardioplegic solution
05/07/2003EP1307205A2 Use of 7alpha-hydroxy-estradiol, 7alpha-hydroxy-dehydroepiandrosterone and 7alpha-hydroxy-pregnenolone derivatives for treating acute cellular degeneration
05/07/2003EP1307201A2 Selective pde 2 inhibitors, used as medicaments for improving cognition
05/07/2003EP1307193A1 Agonists of follicle stimulating hormone activity
05/07/2003EP1307192A1 New use of angiotensin ii antagonists
05/07/2003EP1307183A2 Treatment of the insulin resistance syndrome with selective cgmp pde5 inhibitors
05/07/2003EP1307108A2 Oil/fat composition
05/07/2003EP1259194A4 Bulbous valve and stent for treating vascular reflux
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1143996B1 Use of a bpi protein for the preparation of a medicament for treating chronic cardiac disease
05/07/2003EP1140825B1 Melatonin derivatives and medicine containing same
05/07/2003EP1112251B1 Azetidine derivatives, preparation and medicines containing them
05/07/2003EP1107775B1 Composition containing pyrrolizidine-alkaloid-free petasites
05/07/2003EP1032414B1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders
05/07/2003EP1019055B1 Endothelin antagonist and beta receptor blocking agent as combined preparations
05/07/2003EP1001956B1 2,3-benzodiazepine derivatives
05/07/2003EP0973511B1 Use of sibutramine analogues to lower lipid levels
05/07/2003EP0966454B1 Disubstituted bicyclic heterocycles, their production and use as medicaments
05/07/2003EP0912520B1 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties
05/07/2003EP0889880B1 Eprosartan dihydrate and a process for its production and formulation
05/07/2003EP0841929B1 Quinolones and their therapeutic use
05/07/2003EP0765314B1 Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
05/07/2003EP0752861B1 use of STEROID 5-ALPHA-REDUCTASE INHIBITORS in the manufacture of a medicament for TREATING CARDIOVASCULAR DISEASE
05/07/2003EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/07/2003CN1416428A Compounds having antitumor activity: process for their prepn.and pharmaceutical compsns. contg. them
05/07/2003CN1416421A New CCRS modulators: benzimidazoles or benzotriazoles
05/07/2003CN1416411A Substance for use in dietary supplementation or for prepn. of medicament for treating non-insulin dependent diabetes mellitus, Hypertension and/or metabolic syndrome
05/07/2003CN1416354A Vascular endothelial growth factor 2
05/07/2003CN1416341A Stable emulsion compsns
05/07/2003CN1416340A Compsns for delivery of contisol antagonist
05/07/2003CN1416339A IL-8 receptor antagonsts
05/07/2003CN1415596A Amine derivative possessing the function of anti-pulmonary hypertension and its application in pharmacological science
05/07/2003CN1415378A Injection of freeze-dried powder of growth hormone release inhibiting hormone and its preparation method
05/07/2003CN1415374A Chinese traditional medicine for curing diseases of cerebral hemorrhage, cerebral infarction and related sequela and its preparation method
05/07/2003CN1415360A Chinese traditional medicine for curing hemiparalysis caused by apoplexia and its preparation method
05/07/2003CN1415356A Medicament containing snail powder
05/07/2003CN1415350A Capsule (tablet) made from 5 pure Chinese medicinal plants for curing cardiovascular diseases, cerebrovascular disease and its preparation method
05/07/2003CN1415345A Drug for curing scald, hrut and inflammations as well as hemorrhoids
05/07/2003CN1415343A Patent Chinese medicine for curing coronary heart disease and its preparation method
05/07/2003CN1415310A Nano selenium of chitin and its preparation method
05/07/2003CN1415309A Nano selenium of Melatonin and its preparation method
05/07/2003CN1415308A Nano selenium of amino acid and its preparation method
05/07/2003CN1415301A Compound recipe formula containing kurarinone prostaglandin E1 and aspirin, its preparation method and application
05/07/2003CN1415298A Compound Irbesartan capsule for curing high blood pressure
05/07/2003CN1415296A Compsn. containing ligustrazine, penetrating skin paste agent of igustrazine and its preparation method
05/07/2003CN1415293A Alkaloid of matrine category utilized for mainline and its preparation method
05/07/2003CN1107669C 维生素d类似物 Vitamin d analogues
05/07/2003CN1107499C Nitric oxide donor compsns. and method for treating anal disorders
05/06/2003US6559313 Adenosine derivatives such as (1S,2R,3S,4R)-2,3-dihydroxy-4-(6-(1-(4-trifluormethylpyridin-2-yl)pyrrolidin-3(S)-yl-amino)purin-9-yl)cyclopentanecarboxylic acid isopropylamide
05/06/2003US6559293 Topiramate sodium trihydrate
05/06/2003US6559185 Nitromethyl ketone compounds having aldose reduction inhibiting properties and methods for their use
05/06/2003US6559168 Thiazolyl-acid amide derivatives useful as inhibitors of PDE4 isozymes
05/06/2003US6559163 Agonists, antagonists or inverse agonists for GABAA brain receptors; useful in diagnosis and treatment of anxiety, depression
05/06/2003US6559162 Azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
05/06/2003US6559159 Kappa opioid receptor ligands
05/06/2003US6559155 Pyrimidinone derivatives for the treatment of atherosclerosis
05/06/2003US6559148 Administering a therapeutically effective amount of a compound which is a P2Y purinoreceptor antagonist such as Basilen Blue
05/06/2003US6559147 3-((3,5-difluoro-6-(3-(1-methylimidazolin-2-yl)phenoxy)-4 -(2,3 -dihydroxypropoxy)pyridin-2-yl)oxy)-4-hydroxybenzamidine, for example
05/06/2003US6559146 Neuroprotective effects by inducing calbindin D28Kd, one of Ca2+-binding proteins
05/06/2003US6559143 Class III electrophysiological activity, drugs which prolong the trans-membrane action potential duration and refractoriness, without affecting cardiac conduction
05/06/2003US6559142 Tricyclic substituted cyclic sulfonamides compound is useful for treating heart disease, multiple sclerosis, arthritis, atherosclerosis, and osteoporosis
05/06/2003US6559126 Peptides blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis, polynucleotides encoding said peptides and methods of use thereof
05/06/2003US6558932 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods
05/06/2003US6558707 Micronized particles in carrier such as a purified, micro-crystalline or alkylated cellulose
05/06/2003US6558692 Over-coated chewing gum formulations
05/06/2003CA2253362C Intracoronary stents containing quinazolinone derivatives
05/06/2003CA2115060C Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity
05/06/2003CA2047802C Pharmaceutical compositions
05/02/2003EP1306376A1 Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-HT2B receptor antagonist
05/02/2003EP1306089A1 Combination of benzimidazoles having angiotensin-II antagonistic activity with diuretics or calcium antagonists
05/02/2003EP1306088A1 Combination of a benzimidazole having angiotensin-II antagonistic activity with a diuretic
05/02/2003EP1306086A2 Use of thiazolidinediones for the treatment of atherosclerosis and eating disorders
05/02/2003EP1306085A1 2-Cyclohexyl-4-phenyl-1H-imidazole derivatives as ligands for the neuropeptide Y5 receptor
05/02/2003EP1306083A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion
05/02/2003EP1305434A2 A human disintegrin protein
05/02/2003EP1305409A2 Renal regulatory elements and methods of use thereof
05/02/2003EP1305404A2 Protein phosphatases
05/02/2003EP1305342A2 Human kininogen d5 domain polypeptides and their use
05/02/2003EP1305334A1 Urocortin proteins and uses thereof
05/02/2003EP1305319A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists
05/02/2003EP1305313A1 Fused heterocyclic derivatives as phosphodiesterase inhibitors